An observational study of methionine-bound zinc with antioxidants for mild to moderate acne vulgaris

Dermatologic Therapy

Volumn 23, Issue 4, 2010, Pages 411-418

  Sardana, Kabir ^a   Garg, Vijay K ^a  

^a LOK NAYAK HOSPITAL   (India)

Author keywords

acne; antioxidants; Zn

Indexed keywords

APC; METHIONINE; ORGANOMETALLIC COMPOUND; ZINC METHIONINE;

ABDOMINAL PAIN; ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMEDO; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PUSTULE; TREATMENT OUTCOME; URTICARIA; ANALOGS AND DERIVATIVES; PATHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ACNE VULGARIS; ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; METHIONINE; ORGANOMETALLIC COMPOUNDS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955045733     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01342.x     Document Type: Article

References (56)

1. Murray MT, Pizzorno JE, Acne. Textbook of natural medicine, 2nd ed. 1999 : Churchill Livingstone, New York : 1033 1036.
2. Michaëlsson G, Juhlin L, Ljunghall K. A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol 1977 : 97 : 561 566.
3. Michaëlsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol 1977 : 113 : 31 36. (Pubitemid 8020125)
4. Hillström L, Pettersson L, Hellbe L, Kjellin A, Leczinsky CG, Nordwall C. Comparison of oral treatment with zinc sulphate and placebo in inflammatory acne. Br J Dermatol 1977 : 97 : 679 684.
5. Göransson K, Liden S, Odsell I. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Dermato Vener (Stockholm) 1978 : 58 : 443 448.
6. Weissmann K, Wadskov S, Sondergaard J. Oral zinc sulphate therapy for acne vulgaris. Acta Dermato Vener (Stockholm) 1977 : 57 : 357 360.
7. Weimar VM, Puhl SC, Smith WH, tenBroeke JE. Zinc sulfate in acne vulgaris. Arch Dermatol 1978 : 114 (12 1776 1778.
8. Cunliffe WJ, Burke B, Dodman B, Gould DJ. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol 1979 : 101 : 321 325.
9. Verma KC, Saini AS, Dhamija SK. Oral zinc sulphate therapy in acute vulgaris: a double-blind trial. Acta Dermato Vener (Stockholm) 1980 : 60 : 337 340.
10. Dreno B, Amblard P, Agache P, Sirot S, Litoux P. Low doses of zinc gluconate for inflammatory acne. Acta Dermato Vener (Stockholm) 1989 : 69 : 541 543.
11. Meynadier J. Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. Eur J Dermatol 2000 : 10 (4 269 273.
12. Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, et al. Acne Research and Study Group. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001 : 203 : 135 140.
13. Wedekind KJ, Hortin AE, Baker DH. Methodology for assessing zinc bioavailability: efficacy estimates for zinc-methionine, zinc sulfate, and zinc oxide. J Anim Sci 1992 : 70 (1 178 187.
14. Vahlquist A, Michaëlsson G, Juhlin L. Acne treatment with oral zinc and vitamin A: effects on the serum levels of zinc and retinol binding protein (RBP). Acta Derm Venereol 1978 : 58 (5 437 442.
15. Nasiri S, Ghalamkarpour F, Yousefi M, Sadighha A. Serum zinc levels in Iranian patients with acne. Clin Exp Dermatol 2009 : 34 (7 e446.
16. Michaëlsson G. Zinc therapy in acrodermatitis enteropathica. Acta Dermato Vener (Stockholm) 1974 : 54 : 377 381.
17. Stéphan F, Revuz J. Zinc salts in dermatology. Ann Dermatol Venereol 2004 : 131 (5 455 460.
18. ® et acne inflammatoire. Impact Médecin 1991 : 85 : 1 7.
19. Stamatiadis B, Bulteau-Portois MC, Mowszowicz I. Inhibition of 5a-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol 1988 : 119 : 627 632.
20. Leake A, Chisholm GD, Habib FK. The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland. J Steroid Biochem 1984 : 20 (2 651 655.
21. Chen W, Zouboulis CC, Orfanos CE. The 5 alpha-reductase system and its inhibitors: recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 1996 : 193 : 177 184.
22. Liao S, Hiipakka R. Selective inhibition of steroid 5a-reductase isoenzymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun 1995 : 214 : 833 838.
23. Evans B, Griffiths K, Morton M. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and iso-flavonoids. J Endocrinol 1995 : 147 : 295 302.
24. Dreno B, Trossaert M, Boiteau HL, Litoux P. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol 1992 : 72 : 250 252.
25. Strauss JS, Stranieri AM. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol 1984 : 11 : 86 89.
26. Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 2005 : 15 (3 152 155.
27. Chvapil M, Stankova L, Zukoski CT, Zukoski C 3rd. Inhibition of some functions of polymorphonuclear leukocytes by in vitro zinc. J Lab Clin Med 1977 : 89 : 135 146. PubMed.
28. Sainte-Marie I, Jumbou O, Tenaud I, Dreno B. Comparative study of the in vitro inflammatory activity of three nickel salts on kerati-nocytes. Acta Derm Venereol 1998 : 78 : 169 172.
29. Tenaud I, Sainte-Marie I, Jumbou O, Litoux P, Dreno B. In vitro modulation of keratinocyte wound healing integrins by zinc, copper and manganese. Br J Dermatol 1999 : 140 : 26 34.
30. Tenaud I, Leroy S, Chebassier N, Dreno B. Zinc, copper and manganese enhanced keratinocyte migration through a functional modulation of keratinocyte integrins. Exp Dermatol 2000 : 9 : 407 416.
31. Gueniche A, Viac J, Lizard G, Charveron M, Schmitt D. Protective effect of zinc on keratinocyte activation markers induced by interferon or nickel. Acta Derm Venereol 1995 : 75 : 19 23.
32. Jarrousse V, Castex-Rizzi N, Khammari A, Charveron M, Dréno B. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol 2007 : 17 (6 492 496.
33. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000 : 406 : 782 787.
34. Kim J. Review of the innate immune response in acne vulgaris:activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 2005 : 211 : 193 198.
35. Jugeau S, Tenaud I, Knol AC, et al. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol 2005 : 153 : 1105 1113.
36. Abdel Fattah NS, Shaheen MA, Ebrahim AA, El Okda ES. Tissue and blood superoxide dismutase activities and malondialdehyde levels in different clinical severities of acne vulgaris. Br J Dermatol 2008 : 159 : 1086 1091.
37. Arican O, Kurutas EB, Sasmaz S. Oxidative stress in patients with acne vulgaris. Mediators Inflamm 2005 : 6 : 380 384. (Pubitemid 41803407)
38. Kurutas EB, Arican O, Sasmaz S. Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris. Acta Dermatovenerol Alp Panonica Adriat 2005 : 14 : 39 42.
39. Akamatsu H, Horio T. The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation. Dermatology 1998 : 196 : 82 85.
40. Basak PY, Gultekin F, Kilinc I. The role of the antioxidative defense system in papulopustular acne. J Dermatol 2001 : 28 : 123 127.
41. Basak PY, Gultekin F, Kilinc I, Delibas N. The effect of benzoyl peroxide and benzoyl peroxide /erythromycin combination on the antioxidative defense system in papulopustular acne. Eur J Dermatol 2002 : 12 : 53 57.
42. Akamatsu H, Horio T, Hattori K. Increased hydrogen peroxide generation by neutrophils from patients with acne inflammation. Int J Dermatol 2003 : 42 : 366 369.
43. Ayres S Jr. Acne vulgaris: correcting pathophysiologic defects versus antibacterial therapy. Int J Dermatol 1986 : 5 : 335 336.
44. Ayres S Jr., Mihan R. Acne vulgaris: therapy directed at pathophysiologic defects. Cutis 1981 : 28 : 41 42.
45. El-Akawai Z, Abdel-Latif N, Abdul-Razzak K. Does the plasma level of vitamins A and E affect acne condition? Clin Exp Dermatol 2006 : 31 : 430 434.
46. Michaelsson G, Edqvist LE. Erythrocyte glutathione peroxidase activity in acne vulgaris and the effect of selenium and vitamin E treatment. Acta Derm Venereol (Stockholm) 1984 : 64 : 9 14.
47. Dreno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H. European recommendations on the use of oral antibioticsfor acne. Eur J Dermatol 2004 : 14 : 391 399.
48. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003 : 148 : 467 478.
49. Braha S, Gafitanu E, Alexandrescu G, Groll M, Gherasim P. Anti-microbial activities of organic zinc compounds. Rev Med Chir Soc Med Nat Iasi 1992 : 96 : 249 252.
50. Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 2005 : 15 (3 152 155.
51. Chien XX, Zafra-Stone S, Bagchi M, Bagchi D. Bioavailability, antioxidant and immune-enhancing properties of zinc methionine. Biofactors 2006 : 27 (1-4 231 244.
52. Zinc again. Br Med J 1977 : 1 (6075 1493.
53. Ad hoc Committee report. Systemic antibiotics for treatment of acne vulgaris: efficacy and safety. Arch Dermatol 1975 : 111 : 1630 1636.
54. Sardana K, Garg VK, Sehgal VN, Mahajan S, Bhushan P. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol 2009 : 23 (5 556 560.
55. Torkos S. Acne. Canadian encyclopedia of natural medicine.
56. Ayres S Jr. Acne vulgaris: correcting pathophysiologic defects versus antibacterial therapy. Int J Dermatol 1986 : 5 : 335 336.